Four cholinesterase inhibitors have been approved by the FDA for treating Alzheimer's. Three of these are often prescribed: Aricept (donepezil), Razadyne (galantamine), and Exelon (rivastigmine). The fourth, Cognex (tacrine) is rarely prescribed nowadays, due to its liver toxicity.
